Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is a strong company with ongoing growth opportunities in the virtual healthcare space. The company has a strong presence in both the employer and health plan markets, with potential for continued expansion into new markets. While there are potential challenges, such as competition and slower growth in the BetterHelp segment, Teladoc is well-positioned to benefit from the ongoing transition to virtual healthcare. The company's goal of increasing efficiency, reducing costs, and capturing a larger share of the market could lead to increased profitability and shareholder value in the long term.

Bears say

Teladoc Health is facing various challenges in its business, including fluctuations in growth due to changes in its revenue mix, ongoing membership declines, potential overhang from its investments in AI, and the transition to a more profitable growth model. While the company has a unique advantage in the virtual care market and potential for long-term growth, its near-term financial uncertainty and the need to continue leading the way in virtual care adoption may hinder its success. With a lower price target of $5.50, based on a lower multiple of ~4-4.5x, we reiterate our cautious Market Perform rating on Teladoc Health.

Teladoc (TDOC) has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 16 analysts, Teladoc (TDOC) has a Hold consensus rating as of May 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.